-
- Stock symbol: BMY
- Annual revenue (2007): $19.3 Billion
- Founder(s): William McLaren Bristol & John Ripley Myers
- Bristol-Meyers
- Squibb
- Industry: Pharmaceutical
- Phone: (212) 546-4000
- Fax: (212) 546-4020
- HQ: New York, New York
- CEO: James M. Cornelius
- COO: Lamberto Andreotti
- Staff: 42,000
- Other key people: Robert T. Zito
-
-
Bristol-Myers Squibb is a large pharmacuetical company, that specializes in the development of cardiovascular drugs and technology. Also know as "BMS", the company also makes antipsychotic, oncology, and virology medications. BMS develops its various products through subsidiaries like Mead Johnson which makes infant formula and other nutritional products for children.
-
Key Dates
- 1887: Bristol-Meyers founded
- 1858: Squibb founded
- 1989: Bristol-Myers Squibb was founded through a merger
- 2001: Acquired Dupont Pharmaceuticals for $7.8 Billion
-
-
Bristol-Myers Squibb Competitors
- Merck: Official Site | Hoovers
- Novartis: Official Site | Hoovers
- Pfizer: Official Site | Hoovers
- Sanofi-Aventis: Official Site | Hoovers
- This page was created by Donald Mc, a Part Time Guide in the Mahalo Greenhouse (see the original), and curated by Colette L.
- If you'd like to help us create the best spam free search results on the Internet, apply to be a Part Time Guide!</em>
-
On Twitter Powered by Twitter
-
Bristol-Myers Squibb 2735 http://is.gd/501JL
-
Stroke News: FDA approves sNDA for pediatric autism drug ABILIFY: Bristol-Myers Squibb Company and .. http://twurl.nl/485sb6
-
Obesity News: FDA approves sNDA for pediatric autism drug ABILIFY: Bristol-Myers Squibb Company an.. http://twurl.nl/kl8lfe
-
FDA approves sNDA for pediatric autism drug ABILIFY|Bristol-Myers Squibb Company and Otsuka Pharmaceutical Co., .. http://oohja.com/x2wHG
-
Bristol-Myers Squibb's looking to divest Mead Johnson. Will Nestle, Danone or Heinz take the bite?
view more tweets...
-
About this page
-
Page Views0
No one is currently managing this page.
This page currently has no vertical manager.
